Trials / Completed
CompletedNCT02154971
Assessment of Age-related Hearing Loss in HIV-1 Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 206 (actual)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Network
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The ageing process is known to be accelerated in HIV-infected patients, compared to the general population. Normal age-related hearing loss (presbyacusia) is a frequent phenomenon, affecting more than 70% of people above 65 years. It is believed to be mostly the consequence of a mitochondrial damage caused by oxidative stress. Risk factors for accelerated age-related hearing loss are present in many HIV-infected patients : chronic inflammation, smoking, diabetes, etc. The global aim is to measure the prevalence of presbyacusia in a well controlled HIV positive population in France, and to compare it to HIV negative controls matched for age and sex. 90 HIV positive patients and 90 age- and sex- matched HIV negative controls will undergo a screening for presbyacusia (pure-tone, speech and evoked-response audiometry). We expect to find an increased prevalence of presbyacusia in HIV-infected patients, as compared to controls matched for age and sex.
Conditions
Timeline
- Start date
- 2013-11-18
- Primary completion
- 2019-02-26
- Completion
- 2019-02-26
- First posted
- 2014-06-04
- Last updated
- 2020-09-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02154971. Inclusion in this directory is not an endorsement.